STOCK TITAN

Patrick A. Mayes to sell 6,055 Incyte (NASDAQ: INCY) shares after options

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Patrick A. Mayes filed to sell common stock of Incyte Corporation through Morgan Stanley Smith Barney LLC. The planned transaction covers 6,055 shares of common stock, related to a stock option exercise, with an aggregate market value of $729,203.65 as of the filing. The shares are listed on NASDAQ and the transaction date is August 3, 2026. During the prior three months, Mayes also sold 41,899 shares of common stock for an aggregate value of $5,005,186.06 on July 31, 2026.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 6,055 shares Common stock sale related to stock option exercise dated August 3, 2026
Aggregate market value of planned sale $729,203.65 Value associated with 6,055 Incyte common shares to be sold
Shares sold in past 3 months 41,899 shares Common stock sale by Patrick A. Mayes on July 31, 2026
Aggregate value of prior sale $5,005,186.06 Value of 41,899 Incyte shares sold during the past three months
Planned sale date 08/03/2026 Date for the sale of 6,055 shares disclosed in the filing
Prior sale date 07/31/2026 Date of the 41,899-share sale reported in past 3 months
Form 144 regulatory
"Form 144: Filer Information and securities to be sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Stock Option Exercise financial
"Common | 08/03/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
aggregate market value financial
"Common | ... | 6055 | 729203.65 | 202697746 | 08/03/2026"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the Form 144 filing for INCY by Patrick A. Mayes disclose?

The filing discloses that Patrick A. Mayes plans to sell 6,055 shares of Incyte common stock following a stock option exercise. The planned sale is through Morgan Stanley Smith Barney LLC and is dated August 3, 2026.

How many INCY shares is Patrick A. Mayes planning to sell under this Form 144?

Patrick A. Mayes is planning to sell 6,055 shares of Incyte common stock. These shares relate to a stock option exercise and carry an aggregate market value of $729,203.65 as referenced in the Form 144 filing.

What is the aggregate market value of the planned INCY share sale?

The planned sale of 6,055 Incyte shares has an aggregate market value of $729,203.65. This value reflects the market price used in the Form 144 disclosure for the shares to be sold on August 3, 2026.

What prior INCY stock sales by Patrick A. Mayes are reported in the last 3 months?

The filing reports that on July 31, 2026, Patrick A. Mayes sold 41,899 shares of Incyte common stock. These earlier sales had an aggregate value of $5,005,186.06 over the past three months as disclosed in the Form 144.

Through which broker is the planned INCY share sale being executed?

The planned sale of 6,055 Incyte shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker is listed with an office at 1 New York Plaza, 8th Floor, New York, NY 10004 in the disclosure.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature